Skip to main content
HCPCS J1954 · Level II · Part B drug

J1954: leuprolide acetate for depot suspension (Lutrate Depot), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1954

Billing unit
7.5 MG
Inj leu acet lutr dpt 7.5 mg
ASP payment limit
$683.86
October 2026; -0.5% vs July 2026
Practitioner MUE
3
MAI 3
OPPS status
SI K
APC 9136
NCCI exposure
no PTP pairs
Coverage articles
2
9 states

TL;DR

HCPCS J1954 is the Level II code for Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg, billed per 7.5 MG. The Medicare Part B ASP payment limit for October 2026 is $683.86 per billing unit, down 0.5% from July 2026. The practitioner MUE allows up to 3 units per date of service (MAI 3), so a full 3-unit day is $2,051.58 at the current limit. Under OPPS it carries status indicator K in APC 9136. J1954 is billed in units of 7.5 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names leuprolide acetate for depot suspension: J1951 (Fensolvi from Tolmar Inc.; billed per 0.25 mg). The ASP crosswalk maps 2 NDCs to it, sold as Leuprolide Acetate, Lutrate Depot by Cipla USA, Inc., Avyxa Pharma, LLC. 2 Medicare coverage articles list the code across 9 states, including A52453.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1954 at $683.86 per 7.5 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $687.287 in July 2026. Beneficiary coinsurance is 14%.

ASP payment limits for J1954
QuarterPayment limitPerCoinsurance
October 2026$683.867.5 MG14%
July 2026$687.2877.5 MG—
CMS note: Inflation-adjusted coinsurance

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 2 NDCs from 2 labelers to J1954. Report the NDC in the claim's drug segment and bill the number of J1954 units that equals the quantity administered divided by 7.5 MG; the last column gives units per full package.

NDCs that crosswalk to J1954
NDCDrug nameLabelerPackage sizeBilling units / package
69097-0909-50Leuprolide AcetateCipla USA, Inc.1 × 13
83831-0134-01Lutrate DepotAvyxa Pharma, LLC1 × 13

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for J1954. For practitioners the limit is 3 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J1954 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services33 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital33 Date of Service Edit: ClinicalPrescribing Information

MUE for J1954 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1954 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1954 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1954 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

2 current Medicare Administrative Contractor articles list J1954 in their HCPCS tables, covering 9 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J1954
ArticleTitleContractor(s)StatesRelated LCD
A52453Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) AnalogsWellpoint FederalCT IL MN NY WIL33394
A59160Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) AnalogsPalmetto GBANC SC VA WVL39387

Diagnoses Medicare contractors cover for J1954

2 billing and coding articles attach a covered diagnosis list to J1954: 180 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for J1954
ICD-10-CMDescription (FY2027)Articles covering
C61Malignant neoplasm of prostate2 of 2
Z85.46Personal history of malignant neoplasm of prostate2 of 2
C08.0Malignant neoplasm of submandibular gland1 of 2
C08.1Malignant neoplasm of sublingual gland1 of 2
C08.9Malignant neoplasm of major salivary gland, unspecified1 of 2
C48.0Malignant neoplasm of retroperitoneum1 of 2
C48.1Malignant neoplasm of specified parts of peritoneum1 of 2
C48.2Malignant neoplasm of peritoneum, unspecified1 of 2
C48.8Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum1 of 2
C50.011Malignant neoplasm of nipple and areola, right female breast1 of 2
C50.012Malignant neoplasm of nipple and areola, left female breast1 of 2
C50.019Malignant neoplasm of nipple and areola, unspecified female breast1 of 2
C50.021Malignant neoplasm of nipple and areola, right male breast1 of 2
C50.022Malignant neoplasm of nipple and areola, left male breast1 of 2
C50.029Malignant neoplasm of nipple and areola, unspecified male breast1 of 2
165 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J1954 are counted here: a group whose instructions name J1954, together with any unnamed groups directly after it, read as continuations of those instructions. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J1954, by article
ArticleContractorGroups that applyCovered codes for J1954Full list
A52453Wellpoint Federalgroup 14 applies to J19542On LCD L33394
A59160Palmetto GBAgroup 2 applies to J1954180On LCD L39387

Local coverage policies that list J1954

2 active Local Coverage Determinations list J1954 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1954 carries status indicator K and is assigned to APC 9136, with a published national unadjusted payment of $683.86. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1954 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $683.86 per 7.5 MG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J1954 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1954

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1954

What does HCPCS code J1954 describe?

J1954 is defined by CMS as "Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg". Each billing unit represents 7.5 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1954 a CPT code?

No. J1954 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as leuprolide acetate for depot suspension (Lutrate Depot); CPT codes are five-character codes maintained by the AMA. On a Part B claim J1954 reports the drug itself in 7.5 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1954 in October 2026?

The ASP-based payment limit is $683.86 per 7.5 MG, with 14% beneficiary coinsurance. The July 2026 limit was $687.287. Commercial payers use their own fee schedules.

How many units of J1954 can be billed per day?

The practitioner Medically Unlikely Edit is 3 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J1954?

The October 2026 ASP crosswalk lists 2 NDCs from 2 labelers: Leuprolide Acetate (Cipla USA, Inc.); Lutrate Depot (Avyxa Pharma, LLC). For example NDC 69097-0909-50 (package size 1) equals 3 billing units of J1954.

Does J1954 have NCCI bundling edits?

No active practitioner PTP pairs list J1954 as a column-1 or column-2 code in the v323r0 release.

J1954 vs J1951: what is the difference?

Both are HCPCS Level II codes whose descriptor names leuprolide acetate for depot suspension. What sets J1951 apart: Fensolvi from Tolmar Inc.; billed per 0.25 mg. J1954 is billed per 7.5 mg, limit $683.86, MUE 3; J1951 is billed per 0.25 mg, limit $141.696, MUE 180. Report the code whose descriptor matches the product and setting in the record.

Which Medicare coverage articles mention J1954?

2 current Billing and Coding Articles in the Medicare Coverage Database list J1954, covering 9 states: A52453 (Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs); A59160 (Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs).

What diagnosis codes support J1954?

2 Medicare billing and coding articles list 180 covered ICD-10-CM codes for J1954 between them, for example C61 (Malignant neoplasm of prostate); Z85.46 (Personal history of malignant neoplasm of prostate); C08.0 (Malignant neoplasm of submandibular gland); C08.1 (Malignant neoplasm of sublingual gland); C08.9 (Malignant neoplasm of major salivary gland, unspecified). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.